摘要
目的研究依托咪酯、丙泊酚联合芬太尼应用于宫腔镜手术的安全性和有效性.方法 80例ASAⅠ~Ⅱ级行宫腔镜手术的患者随机分为两组,每组40例.两组患者静脉注射芬太尼10μg/kg,随后丙泊酚组(P组)静脉推注丙泊酚1.5~2.0 mg/kg后以0.08~0.12 mg/(kg.min)持续输注;依托咪酯组(E组)静脉推注依托咪酯0.30~0.35 mg/kg后以10~15μg/(kg.min)持续输注.记录麻醉效果、不良反应、生命体征等.结果两组患者VAS评分和满意度相似(P>0.05),不良反应发生率相近(P>0.05),P组平均动脉压和心率在T1、T2时刻较E组及本组基础值降低(Ρ<0.01),SpO2≤90%发生例数高于E组(Ρ<0.01).结论依托咪酯联合芬太尼运用于宫腔镜手术镇痛效果完善,安全性好,值得临床推广运用.
Objective To compare the safety and feasibility of etomidate and propofol with fentanyl and propofol (1.5 -2 mg/kg) , then propofol 0.08 - 0.12 mg/(kg.min) was slowly injected intravenously. In group E (n = 40) , patients were injected a dose of fentanyl (10 μg/kg) and etomidate (0.30 - 0.35 mg/kg) and then received etomidate 10 - 15 μg/(kg.min) intravenously. Antalgic effect, side effects and vital signs were recorded. Results There was no difference in VAS scores, satisfaction of the patients and side effects between the two groups (P 〉 0.05 ). Compared with group E, MAP and HR in group P decreased significantly at T1 and T2 (P 〈 0.01) , and the incidence of respiratory depression was higher (P 〈 0.01 ). Conclusions Etomidate with fentanyl anaesthesia is safe and has better analgesic effect in the hysteroscopic surgery. Therefore, it is worth extending in clinic practice.
出处
《昆明医学院学报》
2011年第10期105-108,共4页
Journal of Kunming Medical College